Montelukast För Barn Från 2 Till 5 År Accord (Montelukast)

Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1 on airway smooth muscle and inflammatory cells. This inhibition prevents leukotriene‑mediated bronchoconstriction, mucus production, and vascular leakage, thereby reducing airway inflammation and improving breathing in susceptible children.

The appropriate dose of Montelukast for children aged two to five years is determined by the prescribing healthcare professional based on the child's weight, age, and clinical condition. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Montelukast during pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Montelukast works by blocking leukotriene receptors, whereas inhaled corticosteroids reduce airway inflammation through a different pathway. Montelukast is often used as an add‑on therapy or alternative in patients who cannot tolerate steroids, but inhaled corticosteroids remain the first‑line treatment for persistent asthma in most guidelines.

Montelukast För Barn Från 2 Till 5 År Accord should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Montelukast is taken orally, usually as a chewable tablet or oral granule that can be mixed with a small amount of food or liquid. The exact form and administration instructions are provided by the prescriber, and the dose should be given at the same time each day.

Serious risks include rare allergic reactions such as rash, angioedema, or anaphylaxis, as well as neuropsychiatric events like mood changes, agitation, depression, or suicidal thoughts. Any signs of these reactions require immediate medical attention.

Children younger than two years, patients with known hypersensitivity to Montelukast or any component of the formulation, and individuals with severe hepatic impairment should not use this product unless specifically advised by a qualified healthcare professional.